Entera Bio annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Entera Bio Operating Expenses Growth & History (ENTX)
Entera Bio's operating expenses was $11.5M for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.5M | $1.9M | +20.17% |
| 2024 | 2024-12-31 | $9.6M | $703,000 | +7.91% |
| 2023 | 2023-12-31 | $8.9M | −$4.2M | −31.87% |
| 2022 | 2022-12-31 | $13.1M | $635,000 | +5.11% |
| 2021 | 2021-12-31 | $12.4M | $1.2M | +10.52% |
| 2020 | 2020-12-31 | $11.2M | −$247,000 | −2.15% |
| 2019 | 2019-12-31 | $11.5M | — | — |
Entera Bio quarterly operating expenses
Q2.19
Q2.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.6M | $1.9M | +71.03% |
| Q1 2026 | 2026-03-31 | $3.5M | $976,000 | +38.08% |
| Q4 2025 | 2025-12-31 | $3.0M | $705,000 | +30.17% |
| Q3 2025 | 2025-09-30 | $3.3M | $235,000 | +7.78% |
| Q2 2025 | 2025-06-30 | $2.7M | $494,000 | +22.72% |
| Q1 2025 | 2025-03-31 | $2.6M | $501,000 | +24.30% |
| Q4 2024 | 2024-12-31 | $2.3M | $374,000 | +19.05% |
| Q3 2024 | 2024-09-30 | $3.0M | $635,000 | +26.61% |
| Q2 2024 | 2024-06-30 | $2.2M | −$156,000 | −6.70% |
| Q1 2024 | 2024-03-31 | $2.1M | −$150,000 | −6.78% |
| Q4 2023 | 2023-12-31 | $2.0M | −$1.1M | −36.14% |
| Q3 2023 | 2023-09-30 | $2.4M | −$481,000 | −16.78% |
| Q2 2023 | 2023-06-30 | $2.3M | −$930,000 | −28.53% |
| Q1 2023 | 2023-03-31 | $2.2M | −$1.6M | −42.53% |
| Q4 2022 | 2022-12-31 | $3.1M | −$1.0M | −25.33% |
| Q3 2022 | 2022-09-30 | $2.9M | −$428,000 | −12.99% |
| Q2 2022 | 2022-06-30 | $3.3M | $680,000 | +26.36% |
| Q1 2022 | 2022-03-31 | $3.8M | $1.4M | +58.85% |
| Q4 2021 | 2021-12-31 | $4.1M | — | — |
| Q3 2021 | 2021-09-30 | $3.3M | — | — |
| Q2 2021 | 2021-06-30 | $2.6M | −$968,000 | −27.28% |
| Q1 2021 | 2021-03-31 | $2.4M | — | — |
| Q2 2020 | 2020-06-30 | $3.5M | $1.5M | +73.84% |
| Q2 2019 | 2019-06-30 | $2.0M | — | — |
Entera Bio operating expenses trends
Over the last five fiscal years, Entera Bio's operating expenses increased from $11.2M to $11.5M, a change of $296,000. The latest reported quarter, Q2 2026, shows $4.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗